| Literature DB >> 29414990 |
Marie Garvey1, Nicolás M Suárez2, Karen Kerr2, Ralph Hector2, Laura Moloney-Quinn1, Sean Arkins3, Andrew J Davison2, Ann Cullinane1.
Abstract
Equid herpesvirus 8 (EHV-8), formerly known as asinine herpesvirus 3, is an alphaherpesvirus that is closely related to equid herpesviruses 1 and 9 (EHV-1 and EHV-9). The pathogenesis of EHV-8 is relatively little studied and to date has only been associated with respiratory disease in donkeys in Australia and horses in China. A single EHV-8 genome sequence has been generated for strain Wh in China, but is apparently incomplete and contains frameshifts in two genes. In this study, the complete genome sequences of four EHV-8 strains isolated in Ireland between 2003 and 2015 were determined by Illumina sequencing. Two of these strains were isolated from cases of abortion in horses, and were misdiagnosed initially as EHV-1, and two were isolated from donkeys, one with neurological disease. The four genome sequences are very similar to each other, exhibiting greater than 98.4% nucleotide identity, and their phylogenetic clustering together demonstrated that genomic diversity is not dependent on the host. Comparative genomic analysis revealed 24 of the 76 predicted protein sequences are completely conserved among the Irish EHV-8 strains. Evolutionary comparisons indicate that EHV-8 is phylogenetically closer to EHV-9 than it is to EHV-1. In summary, the first complete genome sequences of EHV-8 isolates from two host species over a twelve year period are reported. The current study suggests that EHV-8 can cause abortion in horses. The potential threat of EHV-8 to the horse industry and the possibility that donkeys may act as reservoirs of infection warrant further investigation.Entities:
Mesh:
Year: 2018 PMID: 29414990 PMCID: PMC5802896 DOI: 10.1371/journal.pone.0192301
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of sequencing and genome data for the four Irish EHV-8 strains.
| EHV-8/IR/2003/19 | EHV-8/IR/2010/47 | EHV-8/IR/2010/16 | EHV-8/IR/2015/40 | |
|---|---|---|---|---|
| Total trimmed reads (no.) | 3,281,110 | 4,231,272 | 3,624,440 | 2,810,830 |
| EHV-8 reads (no.) | 237,890 | 1,207,021 | 886,413 | 175,652 |
| Coverage depth (reads/nt) | 237 | 1195 | 878 | 175 |
| Genome size (bp) | 149,600 | 149,800 | 149,405 | 149,667 |
| UL size (bp) | 112,966 | 113,368 | 112,917 | 113,337 |
| US size (bp) | 12,148 | 12,316 | 12,358 | 12,346 |
| TRL/IRL size (bp) | 32 | 32 | 32 | 32 |
| TRS/IRS size (bp) | 12,211 | 12,026 | 12,033 | 11,960 |
| GenBank accession no. | MF431611 | MF431612 | MF431613 | MF431614 |
| European Nucleotide Archive study accession no. | PRJEB24126 | PRJEB24126 | PRJEB24126 | PRJEB24126 |
Abbreviations: EHV-8, equid herpesvirus 8, UL, unique long region; US, unique short region; TRL/IRL and TRS/IRS, terminal and internal inverted repeats flanking UL and US, respectively.
Fig 1Maximum likelihood phylogenetic tree of ORF30 amino acid sequences based on the JTT matrix-based model.
Details of the sequences are in S1 Table of the Supporting Information. The scale bar represents the number of substitutions per site. Bootstrap values after 1000 replications are indicated at major nodes.
Fig 2Map of the equid herpesvirus 8 (EHV-8) genome.
The coordinates are based on the 149600 bp sequence of EHV-8/IR/2003/19. Predicted protein-coding regions are shown by coloured arrows with names below. Red open reading frames (ORFs) were inherited from the ancestor of family Herpesviridae and blue ORFs from the ancestor of subfamily Alphaherpesvirinae. Orange ORFs are specific to certain lineages within subfamily Alphaherpesvirinae. Inverted repeats TRS/IRS flanking US are coloured yellow, and inverted repeats TRL/IRL flanking UL are shown by green vertical lines at 1–32 and 112999–113030 bp. A third green vertical line marks a third copy of the TRL/IRL sequence that is part of a more extensive inverted repeat at 1–87 and 547–633 bp. Tandem reiterations are marked by grey shading, and origins of DNA replication by vertical red lines.
Fig 3Conserved sequences near the genome termini of equid varicelloviruses.
An alignment of sequences from the four Irish equid herpesvirus (EHV) 8 (EHV-8) strains, EHV-9 P19 (AP010838.1), EHV-1 AB4 (AY665713.1) and EHV-4 NS80567 (AF030027.1) is shown. In each sequence, TRL is boxed, the terminal nucleotides are shaded black, and conserved regions AnTn and γ (which are present near the left and right termini, respectively) are underlined. Ellipses denote the remainder of the genome.
Tandem reiterations in EHV-8 genomes.
| Number of units | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Location (bp) | Protein-coding region | Unit size (bp) | Partial unit size (bp) | Unit sequence (5’-3’) | EHV-8/IR/2003/19 | EHV-8/IR/2010/47 | EHV-8/IR/2010/16 | EHV-8/IR/2015/40 | EHV-8 Wh |
| 97–199 | / | 17 | 5 | 6 | 18 (1+17 | 9 (3+6 | 13 | _ | |
| 43719–43743 | ORF24 | 63 | – | 2 | 4 | 2 | 5 | 5 | |
| 44338–44718 | ORF24 | 33 | 18 | 11 | 18 | 10 | 6 | 1 | |
| 44754–44915 | ORF24 | 12 | 6 | 13 | 9 | 11 | 14 | 7 | |
| 44995–45165 | ORF24 | 45 | 36 | 3 | 3 | 2 | 3 | 2 | |
| 73593–73868 | / | 32 | 20 | 8 | 9 | 7 | 12 | 1 | |
| 108616–108855 | / | 18 | 6 | 13 | 12 | 21 | 28 | 11 | |
| 112183–112582 | / | 14 | 7 | 28 | 16 | 20 | 15 | 15 | |
| 113199–113499 | / | 15 | _ | 20 | 13 (6+7 | 19 | 19 | 14 | |
| 113500–13795 | / | 12 | _ | 24 | 18 | 8 | 11 | 12 | |
| 120998–121049 | / | 14 | 10 | 3 | 10 | 5 | 6 | 11 | |
| 121096–121257 | / | 20 | 2 | 8 | 2 | 4 | 5 | 2 | |
| 1213625–123802 | / | 22 | 2 | 8 | 9 | 12 | 6 | 8 | |
| 129291–129481 | ORF71 | 15 | 11 | 12 | 17 | 18 | 17 | _ | |
| 129594–129632 | ORF71 | 15 | 7 | 2 | 9 | 3 | 5 | _ | |
| 129631–129855 | ORF71 | 15 | – | 15 | 13 | 22 | 19 | _ | |
Abbreviations: EHV-8, equid herpesvirus 8; bp, base pair; ORF, open reading frame.
1 In EHV-8/IR/2003/19.
2 Not located in a predicted protein coding region.
3 Repeat units exhibiting sequence variation.
4 Not present.
5 Inverted sequence in TRS (terminal inverted repeat flanking US (unique short sequence)).
Amino acid sequence identity of genes of the Irish EHV-8 strains to their homologues in EHV-1 and EHV-9.
| ORF | HSV-1 equivalent | Protein | Identity to EHV-1 strain V592 (range, %) | Identity to EHV-9 strain P19 (range, %) |
|---|---|---|---|---|
| 1 | UL56 | Membrane protein UL56 | 91.08 | |
| 2 | _ | Membrane protein V1 | 85.85–86.34 | |
| 3 | _ | Myristylated tegument protein CIRC | 90.27–90.66 | |
| 4 | UL55 | Nuclear protein UL55 | 92.50 | |
| 5 | UL54 | Multifunctional expression regulator | 93.40–93.61 | |
| 6 | UL53 | Envelope glycoprotein K | 97.95 | 97.95 |
| 7 | UL52 | Helicase-primase primase subunit | 93.06–93.24 | |
| 8 | UL51 | Tegument protein UL51 | 95.91–96.32 | |
| 9 | UL50 | Deoxyuridine triphosphatase | 96.62–97.23 | 96.62–97.23 |
| 10 | UL49A | Envelope glycoprotein N | 94.0–95.0 | |
| 11 | UL49 | Tegument protein VP22 | 91.47 | |
| 12 | UL48 | Transactivating tegument protein VP16 | 92.20–92.43 | |
| 13 | UL47 | Tegument protein VP13/14 | 84.73–84.95 | |
| 14 | UL46 | Tegument protein VP11/12 | 91.86–92.0 | |
| 15 | UL45 | Membrane protein UL45 | 85.38–85.84 | |
| 16 | UL44 | Envelope glycoprotein C | 93.06–93.27 | |
| 17 | UL43 | Envelope protein UL43 | 96.25 | |
| 18 | UL42 | DNA polymerase processivity subunit | 96.05–96.31 | |
| 19 | UL41 | Tegument host shut-off protein | 94.36 | |
| 20 | UL40 | Ribonucleotide reductase subunit 2 | 96.26–96.57 | |
| 21 | UL39 | Ribonucleotide reductase subunit 1 | 96.32 | |
| 22 | UL38 | Capsid triplex subunit 1 | 95.05–95.26 | |
| 23 | UL37 | Tegument protein UL37 | 93.43–93.53 | |
| 24 | UL36 | Large tegument protein | 86.95–89.66 | |
| 25 | UL35 | Small capsid protein | 95.79–96.63 | |
| 26 | UL34 | Nuclear egress membrane protein | 94.54–94.90 | |
| 27 | UL33 | DNA packaging protein | 88.54–89.31 | |
| 28 | UL32 | DNA packaging protein UL32 | 89.69–89.85 | |
| 29 | UL31 | Nuclear egress lamina protein | 97.85 | |
| 30 | UL30 | DNA polymerase catalytic subunit | 95.81–96.06 | |
| 31 | UL29 | Single stranded DNA- binding protein | 97.35–97.43 | |
| 32 | UL28 | DNA packaging terminase subunit 2 | 96.64 | |
| 33 | UL27 | Envelope glycoprotein B | 96.22–96.32 | |
| 34 | _ | Protein V32 | 87.50–88.12 | |
| 35 | UL26 | Capsid maturation protease | 96.59–96.74 | |
| 35.5 | UL26.5 | Capsid scaffold protein | 96.35 | 96.35 |
| 36 | UL25 | DNA packaging tegument protein UL25 | 95.74–96.08 | |
| 37 | UL24 | Nuclear protein UL24 | 94.5 | |
| 38 | UL23 | Thymidine kinase | 97.15 | |
| 39 | UL22 | Envelope glycoprotein H | 95.65 | |
| 40 | UL21 | Tegument protein UL21 | 96.98 | |
| 41 | UL20 | Envelope protein UL20 | 96.58 | |
| 42 | UL19 | Major capsid protein | 99.05–99.12 | |
| 43 | UL18 | Capsid triplex subunit 2 | 97.77 | |
| 44 | UL15 | DNA packaging terminase subunit 1 | 99.04–99.18 | |
| 45 | UL17 | DNA packaging tegument protein UL17 | 96.17–96.31 | |
| 46 | UL16 | Tegument protein UL16 | 95.13–95.40 | |
| 48 | UL14 | Tegument protein UL14 | 90.53 | |
| 49 | UL13 | Tegument serine/threonine protein kinase | 94.61–94.78 | |
| 50 | UL12 | Deoxyribonuclease | 95.04 | |
| 51 | UL11 | Myristylated tegument protein | 90.54 | |
| 52 | UL10 | Envelope glycoprotein M | 97.11 | |
| 53 | UL9 | DNA replication origin-binding protein | 97.51 | |
| 54 | UL8 | Helicase-primase subunit | 92.27–92.41 | |
| 55 | UL7 | Tegument protein UL7 | 94.38–95.04 | |
| 56 | UL6 | Capsid portal protein | 95.21–95.48 | |
| 57 | UL5 | Helicase-primase helicase subunit | 96.14–96.36 | |
| 58 | UL4 | Nuclear protein UL4 | 90.66–91.11 | |
| 59 | _ | Protein V57 | 82.96–83.51 | |
| 60 | UL3 | Nuclear protein UL3 | 96.69 | |
| 61 | UL2 | Uracil- DNA glycosylase | 91.05 | |
| 62 | UL1 | Envelope glycoprotein L | 88.24 | |
| 63 | RL2 | Ubiquitin E3 ligase ICP0 | 86.13–86.66 | |
| 64 | RS1 | Transcriptional regulator ICP4 | 90.37–91.52 | |
| 65 | US1 | Regulatory protein ICP22 | 94.53–94.88 | |
| 66 | US10 | Virion protein US10 | 93.22–93.64 | |
| 67 | _ | Virion protein V67 | 92.7 | |
| 68 | US2 | Virion protein US2 | 84.15–84.48 | |
| 69 | US3 | Serine/threonine protein kinase US3 | 93.19 | |
| 70 | US4 | Envelope glycoprotein G | 91.97–92.21 | |
| 71 | US5 | Envelope glycoprotein J | 73.18–75.83 | |
| 72 | US6 | Envelope glycoprotein D | 90.79–91.04 | |
| 73 | US7 | Envelope glycoprotein I | 90.56 | |
| 74 | US8 | Envelope glycoprotein E | 95.63–95.81 | |
| 75 | US8A | Membrane protein US8A | 83.84–84.61 | |
| 76 | US9 | Membrane protein US9 | 82.64 |
Abbreviations: EHV-8, equid herpesvirus 8; EHV-1, equid herpesvirus 1; EHV-9, equid herpesvirus 9; HSV-1, herpes simplex virus type 1; ORF, open reading frame; UL, US, RL and RS, genes located in UL, US, TRL/IRL, TRS/IRS, respectively (UL, unique long region; US, unique short region; TRL/IRL and TRS/IRS, terminal and internal inverted repeats flanking UL and US, respectively); VP, viral protein; ICP, infected cell protein
1 Nomenclature of HSV-1 homologues or positional counterparts. Genes lacking HSV-1 positional counterparts are indicated by hyphens.
2 The higher identity range in each row is in bold type.
Fig 4Phylogenetic tree of concatenated amino acid sequences of ORF3-ORF76 from the Irish equid herpesvirus 8 (EHV-8) strains, EHV-8 strain Wh and other equid alphaherpesvirus strains.
The tree was constructed by using the maximum likelihood method based on the JTT matrix-based model [30], and is drawn to scale. Bootstrap values from 1000 replicates are shown as percentages at major nodes.